精密诊断市场规模、份额和成长分析（按产品类型、应用、最终用户和地区）- 产业预测 2025-2032

全球精准诊断市场规模预估2023年为680.7亿美元，2024年为805.9亿美元，2032年为3,112.6亿美元，2025-2032年的复合年增长率为18.4%。

精准诊断透过针对患者的健康问题（尤其是在糖尿病和癌症治疗方面）提供及时且个人化的见解，彻底改变了医疗保健领域。由于癌症和神经系统疾病发病率的上升，精准医疗的需求正在飙升。美国国家癌症美国预测，到 2031 年，全球将新增 2,950 万癌症病例，新增 1,640 万癌症相关死亡病例。癌症、结核病和阿兹海默症症等疾病的基因治疗和精准医疗的进步预计将推动收益大幅成长。精准诊断和治疗方法的可自订性是一个关键优势，可以实现个人化的治疗方法而不是通用的解决方案，从而改善患者的治疗效果和医疗效率。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术进步
• 监管格局
• 专利分析

精准诊断市场规模（依产品类型）

• 市场概况
• 耗材
  • 试剂
  • 套件
  • 测定
• 装置
  • 次世代定序(NGS) 系统
  • 聚合酵素链锁反应（PCR）系统
  • 质谱仪系统
  • 其他的
• 软体和服务
  • 资料分析软体
  • 生物资讯服务
  • 咨询服务

精准诊断市场规模（按类型）

• 市场概况
• 基因检测
• 消费者测试
• 深奥的测试
• 其他的

精准诊断市场规模（按应用）

• 市场概况
• 肿瘤学
  • 乳癌
  • 肺癌
  • 大肠直肠癌
  • 其他的
• 心臟病学
• 神经病学
• 感染疾病
• 其他的

精准诊断市场规模（依最终用户划分）

• 市场概况
• 医院
• 诊断实验室
• 研究组织
• 其他的

精准诊断市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Roche（Switzerland）
• GE Healthcare（United States）
• Abbott Laboratories（United States）
• Philips Healthcare（Netherlands）
• Danaher Corporation（United States）
• Quest Diagnostics（United States）
• Fujifilm Medical（Japan）
• Becton, Dickinson and Company（United States）
• Siemens Healthineers（Germany）
• Hologic Inc.（United States）
• QIAGEN（Germany）
• Grifols（Spain）
• Beckman Coulter（United States）
• bioMerieux（France）
• Thermo Fisher Scientific（United States）
• PerkinElmer（United States）
• Illumina（United States）
• Agilent Technologies（United States）
• Bio-Rad Laboratories（United States）
• Merck Group（Germany）

结论和建议

Global Precision Diagnostics Market size was valued at USD 68.07 billion in 2023 and is poised to grow from USD 80.59 billion in 2024 to USD 311.26 billion by 2032, growing at a CAGR of 18.4% during the forecast period (2025-2032).

Precision diagnostics is revolutionizing healthcare by providing tailored, timely insights into patients' health issues, particularly in diabetes and cancer treatment. Given the escalating incidence of cancer and neurological disorders, demand for precision medicine is set to soar. The National Cancer Institute projects a staggering increase of 29.5 million new cancer cases by 2031, alongside a 16.4 million rise in cancer-related fatalities. Advances in gene therapy and precision treatments for conditions like cancer, tuberculosis, and Alzheimer's are expected to drive significant revenue growth. The customizable nature of precision diagnostics and therapies is a critical advantage, allowing for personalized treatment approaches rather than a generic solution, thereby enhancing patient outcomes and healthcare efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Diagnostics Market Segmental Analysis

Global Precision Diagnostics Market is segmented by Product Type, Type, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software & Services. Based on Type, the market is segmented into Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Others. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Infectious Diseases and Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is being driven significantly by the rising demand for personalized therapy, which has gained traction in recent years. Essential tools such as genetic testing and genome sequencing are pivotal in unraveling the molecular foundations of various diseases. In many European nations, there is a proactive approach to screening for genetic disorders, as early detection can mitigate symptoms and lessen disease severity. Additionally, the COVID-19 pandemic highlighted the importance of diagnostic testing in managing outbreaks. Pharmaceutical and biotech firms are actively pursuing preclinical and clinical trials for innovative therapies, including plasma and immunotherapy. This momentum is expected to fuel market growth throughout the forecast period.

Restraints in the Global Precision Diagnostics Market

The Global Precision Diagnostics market faces several restraints that could impede its growth potential, primarily due to a lack of awareness and substantial costs associated with research and development. High R&D expenses deter innovation and advancement in precision diagnostics. While accurate diagnosis remains a top priority for healthcare providers, challenges such as the demand for quicker test results, inefficiencies in current testing methods, and regulatory hurdles for new test kit development further complicate market progress. Additionally, the strict regulatory landscape in many nations continues to pose significant barriers, ultimately hampering the overall expansion of the precision diagnostics sector.

Market Trends of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is experiencing a significant upward trend, driven primarily by the alarming increase in cancer prevalence worldwide. As cancer cases rise, there is an intensified focus on enhancing detection, prevention, and treatment protocols. Innovations such as Next Generation Sequencing (NGS) and the integration of extensive genomic data are revolutionizing the diagnostic landscape, leading to more tailored and effective therapeutic strategies. This fusion of technological advancements and a growing demand for precision medicine is poised to fuel robust growth in the market throughout the forecast period, positioning it as a critical component of modern healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Precision Diagnostics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Consumables
  • Reagents
  • Kits
  • Assays
• Instruments
  • Next-Generation Sequencing (NGS) Systems
  • Polymerase Chain Reaction (PCR) Systems
  • Mass Spectrometry Systems
  • Others
• Software & Services
  • Data Analysis Software
  • Bioinformatics Services
  • Consulting Services

Global Precision Diagnostics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

Global Precision Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others
• Cardiology
• Neurology
• Infectious Diseases
• Others

Global Precision Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Precision Diagnostics Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations